Alan Grossfield

Alan Grossfield

Auto-generated profile, based on publicly available information

Alan Grossfield

Department of Biochemistry and Biophysics, University of Rochester Medical Center

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2003 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
AGAlan Grossfield
Alan Grossfield
PRPengyu Ren
Pengyu Ren
JPJay W. Ponder
Jay W. Ponder


31 August 2006 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
DJDian Jiao
Dian Jiao
CKChristopher King
Christopher King
AGAlan Grossfield
Alan Grossfield
TDThomas A. Darden
Thomas A. Darden
PRPengyu Ren
Pengyu Ren

17 March 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
AGAlan Grossfield
Alan Grossfield
SFScott E. Feller
Scott E. Feller
MPMichael C. Pitman
Michael C. Pitman
Rhodopsin, the G protein-coupled receptor primarily responsible for sensing light, is found in an environment rich in polyunsaturated lipid chains and cholesterol. Biophysical experiments have shown that lipid unsaturation and cholesterol both have significant effects on rhodopsin’s stability and function; ω-3 polyunsaturated chains, such as docosahexaenoic acid (DHA), destabilize rhodopsin and enhance the kinetics of the photocycle, whereas cholesterol has the opposite effect. Here, we use molecular dynamics simulations to investigate the possibility that polyunsaturated chains modulate rhodopsin stability and kinetics via specific direct interactions. By analyzing the results of 26 independent 100-ns simulations of dark-adapted rhodopsin, we found that DHA routinely forms tight associations with the protein in a small number of specific locations qualitatively different from the nonspecific interactions made by saturated chains and cholesterol. Furthermore, the presence of tightly packed DHA molecules tends to weaken the interhelical packing. These results are consistent with recent NMR work, which proposes that rhodopsin binds DHA, and they suggest a molecular rationale for DHA’s effects on rhodopsin stability and kinetics.

1 January 2019 in Living Journal of Computational Molecular Science
Verified
Journal Article
Open access
PDF file
AGAlan Grossfield
Alan Grossfield
PPPa Pa
Pa Pa
DRDaniel Roe
Daniel Roe
ASAndrew J. Schultz
Andrew J. Schultz
DSDaniel Siderius
Daniel Siderius
DZDaniel M. Zuckerman
Daniel M. Zuckerman
The quantitative assessment of uncertainty and sampling quality is essential in molecular simulation. Many systems of interest are highly complex, often at the edge of current computational capabilities. Modelers must therefore analyze and communicate statistical uncertainties so that "consumers'' of simulated data understand its significance and limitations. This article covers key analyses appropriate for trajectory data generated by conventional simulation methods such as molecular dynamics and (single Markov chain) Monte Carlo. It also provides guidance for analyzing some "enhanced" sampling approaches. We do not discuss systematic errors arising, e.g., from inaccuracy in the chosen model or force field.

1 June 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
DHDow P. Hurst
Dow P. Hurst
AGAlan Grossfield
Alan Grossfield
DLDiane L. Lynch
Diane L. Lynch
SFScott Feller
Scott Feller
TRTod D. Romo
Tod D. Romo
PRPatricia Reggio
Patricia Reggio
Recent isothiocyanate covalent labeling studies have suggested that a classical cannabinoid, (-)-7'-isothiocyanato-11-hydroxy-1',1'dimethylheptyl-hexahydrocannabinol (AM841), enters the cannabinoid CB2 receptor via the lipid bilayer (Pei, Y., Mercier, R. W., Anday, J. K., Thakur, G. A., Zvonok, A. M., Hurst, D., Reggio, P. H., Janero, D. R., and Makriyannis, A. (2008) Chem. Biol. 15, 1207-1219). However, the sequence of steps involved in such a lipid pathway entry has not yet been elucidated. Here, we test the hypothesis that the endogenous cannabinoid sn-2-arachidonoylglycerol (2-AG) attains access to the CB2 receptor via the lipid bilayer. To this end, we have employed microsecond time scale all-atom molecular dynamics (MD) simulations of the interaction of 2-AG with CB2 via a palmitoyl-oleoyl-phosphatidylcholine lipid bilayer. Results suggest the following: 1) 2-AG first partitions out of bulk lipid at the transmembrane alpha-helix (TMH) 6/7 interface; 2) 2-AG then enters the CB2 receptor binding pocket by passing between TMH6 and TMH7; 3) the entrance of the 2-AG headgroup into the CB2 binding pocket is sufficient to trigger breaking of the intracellular TMH3/6 ionic lock and the movement of the TMH6 intracellular end away from TMH3; and 4) subsequent to protonation at D3.49/D6.30, further 2-AG entry into the ligand binding pocket results in both a W6.48 toggle switch change and a large influx of water. To our knowledge, this is the first demonstration via unbiased molecular dynamics that a ligand can access the binding pocket of a class A G protein-coupled receptor via the lipid bilayer and the first demonstration via molecular dynamics of G protein-coupled receptor activation triggered by a ligand binding event.